C Frank Bennett Ionis Pharmaceuticals Inc (IONS) insider trading activity

C Frank Bennett is EVP, Chief Scientific Officer of IONIS PHARMACEUTICALS INC. Currently has a direct ownership of 82,679 shares of IONS, which is worth approximately $5.79 Million. The most recent transaction as insider was on Sep 28, 2023, when has been sold 4,460 shares (Common Stock) at a price of $46.5 per share, resulting in proceeds of $207,390. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 82.7K

11.54% 3M change

3.86% 12M change

Total Value Held $5.79 Million

C FRANK BENNETT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 28 2023	SELL Open market or private sale	$207,390 $46.5 p/Share	4,460 Reduced 6.35%	65,754 Common Stock
Aug 31 2023	BUY Other acquisition or disposition	$5,500 $30.56 p/Share	180 Added 0.26%	70,214 Common Stock
Feb 28 2023	BUY Other acquisition or disposition	$11,689 $30.52 p/Share	383 Added 0.54%	70,034 Common Stock
Feb 06 2023	SELL Open market or private sale	$73,553 $40.57 p/Share	1,813 Reduced 2.54%	69,651 Common Stock
Feb 03 2023	BUY Grant, award, or other acquisition	-	3,609 Added 4.81%	71,464 Common Stock
Jan 18 2023	SELL Open market or private sale	$271,374 $38.89 p/Share	6,978 Reduced 9.32%	67,855 Common Stock
Jan 17 2023	BUY Exercise of conversion of derivative security	-	19,417 Added 20.6%	74,833 Common Stock
Aug 31 2022	BUY Other acquisition or disposition	$5,302 $28.97 p/Share	183 Added 0.33%	55,416 Common Stock
Feb 28 2022	BUY Other acquisition or disposition	$9,816 $28.37 p/Share	346 Added 0.62%	55,233 Common Stock
Jan 18 2022	SELL Payment of exercise price or tax liability	$202,587 $30.12 p/Share	6,726 Reduced 10.92%	54,887 Common Stock
Jan 18 2022	BUY Exercise of conversion of derivative security	-	18,842 Added 23.42%	61,613 Common Stock
Aug 31 2021	BUY Other acquisition or disposition	$5,104 $33.8 p/Share	151 Added 0.35%	42,771 Common Stock
Feb 26 2021	BUY Other acquisition or disposition	$4,988 $44.54 p/Share	112 Added 0.26%	42,620 Common Stock
Jan 15 2021	SELL Payment of exercise price or tax liability	$336,305 $61.28 p/Share	5,488 Reduced 11.43%	42,508 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	-	15,520 Added 24.43%	47,996 Common Stock
Dec 04 2020	SELL Open market or private sale	$405,615 $51.04 p/Share	7,947 Reduced 19.66%	32,476 Common Stock
Dec 04 2020	BUY Exercise of conversion of derivative security	$316,847 $39.87 p/Share	7,947 Added 16.43%	40,423 Common Stock
Dec 02 2020	SELL Open market or private sale	$361,960 $51.32 p/Share	7,053 Reduced 17.84%	32,476 Common Stock
Dec 02 2020	BUY Exercise of conversion of derivative security	$281,203 $39.87 p/Share	7,053 Added 15.14%	39,529 Common Stock
Nov 03 2020	SELL Open market or private sale	$701,550 $46.77 p/Share	15,000 Reduced 31.59%	32,476 Common Stock
Nov 03 2020	BUY Exercise of conversion of derivative security	$598,050 $39.87 p/Share	15,000 Added 24.01%	47,476 Common Stock

CFB

C Frank Bennett

EVP, Chief Scientific Officer

Carlsbad, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IONS shares.

Notify only if

Value

Insider Trading

Get notified when an Ionis Pharmaceuticals Inc insider buys or sells IONS shares.

Notify only if

Operation

Value

Type

News

Receive news related to IONIS PHARMACEUTICALS INC

Track Activities on IONS

Account